Pathways to publication in diabetes Tuesday, 19/05/2026 · 06:00 Atlantic Time (Canada) (GMT -3:00) Cost: Free

https://www.bigmarker.com/lancet-webinars/pathways-to-publication-in-diabetes?utm_bmcr_source=hubspot_email_reg2_publishingexcellence_p2pd&_hsmi=418088165&_hsenc=p2ANqtz-8y7MQkmy2DKSUTdWCCanEeEgwWsMrS1-J8AuGHWBnhoAbaQp3rgDUWAGXFVsLneRtj8_NtraRXTv1SQJKPAygp98ROjQ&hsCtaAttrib=209864303118 In this session, expert editors from across The Lancet Group will share practical guidance to help you navigate the publication process and find the best home for your diabetes research, whether you choose to submit your paper to The Lancet or one of the Lancet specialty, Regional Health, or Discovery Science journals. Hear directly from our editorial team: Helena Wang, Asia Executive Editor, The Lancet, China Callam Davidson, Senior Editor and Diabetes Ambassador, The Lancet, UK Marta Koch, Editor-in-Chief, The Lancet Diabetes & Endocrinology, UK Shalini Garg, Editor-in-Chief, The Lancet Regional Health - Southeast Asia, India Charlotte Rowbottom, Deputy Editor, eClinicalMedicine, UK During the webinar, you will: Learn about the different Lancet publication options available for diabetes content. Understand how our article transfer service works to find the best fit for your work. Gain valuable insights from our editorial teams on optimising your manuscript for success. You will also have the opportunity to ask your questions during a live Q&A with our editors.

Editorial Putting rural health first in the fuel crisis The Lancet Regional Health – Western Pacific +++ +...

Mental health systems in Pacific island countries and territories: a scoping review of current evidence Jialing Lina,t Send email to jialing.lin@unsw.edu.au ∙ Xinrui Weia,b,t ∙ Peixin Hanc ∙ Tinghsuan Hsud ∙ Jiaying Sune ∙ Carey Marrf ∙ et al. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(26)00060-X/fulltext?dgcid=hubspot_update_feature_updatealerts_lanwpc&utm_campaign=update-lanwpc&utm_medium=email&_hsenc=p2ANqtz--o2GqMUNn2-bAsgpSlzu8xlzfQIZACmYD_z2ndWbb71tYYqKuGwKMGylEBXYYS8F8ogPKUV0MYqK7Y5_Oy-9UTJyQTpw&_hsmi=418096106&utm_content=417891082&utm_source=hs_email G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination Arkasha Sadhewaa Send email to arkasha.sadhewa@menzies.edu.au ∙ Lydia Visita Panggalob ∙ Illene Nanineb ∙ Ihsan Fadilahc,d ∙ Jontari Hutagalunge ∙ Enny Kenangalemf ∙ et al. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(26)00044-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanwpc&utm_campaign=update-lanwpc&utm_medium=email&_hsenc=p2ANqtz-8208OgfP3ipvri86dv2ytxroFMRL4Y8WVL-MiOq-GiqmnYbTNBp6xh90RlG_gqFSLcuAZLe3PkA2G5H76UKh3YY-7zEQ&_hsmi=418096106&utm_content=417891082&utm_source=hs_email Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic MET exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study Yongfeng Yua ∙ Qisen Guob ∙ Yongchang Zhangc ∙ Jian Fangd ∙ Diansheng Zhonge ∙ Baogang Liuf ∙ et al. https://www.thelancet.com/journals/lanwpc/article/PIIS2666-6065(26)00038-6/fulltext?dgcid=hubspot_update_feature_updatealerts_lanwpc&utm_campaign=update-lanwpc&utm_medium=email&_hsenc=p2ANqtz-9yRE0bEEXAvrVFx-VuqooLlcgjok7P-7b9LMDCNzociNnMOyfolgEJLOSzmzBKSdczvb52HxDpqAmc0w7d2Tv3tIWUlg&_hsmi=418096106&utm_content=417891082&utm_source=hs_email Editorial Putting rural health first in the fuel crisis The Lancet Regional Health – Western Pacific https://www.thelancet.com/journals/lanwpc/issue/vol69nonull/PIIS2666-6065(26)X2002-8

Mental health at the heart of haematology The Lancet Haematology ++... ++

Mental health at the heart of haematology The Lancet Haematology https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00103-1/fulltext?dgcid=hubspot_update_feature_updatealerts_lanhae&utm_campaign=update-lanhae&utm_medium=email&_hsenc=p2ANqtz-92YnmcMUuop3WTnuhyw3wgOEm5OouVQPfp1cvAeyIZJgeIXOUn577ZDPd2y3H7nTHlmW_S6Ai7EKWVMCjRqqZEY2EO_w&_hsmi=418093480&utm_content=417887741&utm_source=hs_email May 2026 Volume 13Number 5e267-e352 https://www.thelancet.com/journals/lanhae/issue/vol13no5/PIIS2352-3026(26)X2004-X Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network Yonatan Edel, MDa,b,* ∙ Penelope E Stein, FRCPathc,* Send email to p.stein@nhs.net ∙ Hassan Kawtharany, MDd,e ∙ Aasne K Aarsand, MDf,g ∙ Prof Michael Badminton, FRCPathh ∙ Prof Manisha C Balwani, MDi ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00044-X/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-90gfx4HRCupVtVa16qATrT39SgEC8P7VIMMxcKXaGI9dlolNoExt3jdJtrvmESdzT4CjIEvtNJ6jHXQ7AwNGsSsMoDzA&_hsmi=418093480&utm_content=417887741&utm_source=hs_email Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial Prof M Lia Palomba, MDa,† Send email to palombam@mskcc.org ∙ Manish R Patel, MDb,† ∙ Toby A Eyre, MBChB MDc ∙ Prof Wojciech Jurczak, MD PhDd ∙ David Lewis, MBChB PhDe ∙ Thomas Gastinne, MDf ∙ et al. https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(26)00037-2/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-_NDe07fzhSLDtUeCCVR8mItl5USxda6fyIhwxtNUjE8eMmH9mfg3i-TFzGq4oi3D4-f4iAmyZpUQg977380nCYKk7NBg&_hsmi=418093480&utm_content=417887741&utm_source=hs_email

Technological mourning after AI updates: mental health and well-being in the GPT-4o/GPT-5 transition Véronique Donard* [1] , José Carlos Ribeiro [2]

https://www.academia.edu/2997-9196/3/2/10.20935/MHealthWellB8256 Introduction: While large language models (LLMs) are increasingly experienced as relational partners, limited empirical research exists regarding how users emotionally experience abrupt changes in these systems. This study investigates the psychological, affective, and cognitive impacts of the temporary removal of GPT-4o and its replacement by GPT-5 in August 2025, mapping the consequences for user well-being through the exploration of the emerging phenomenon of technological mourning. We propose the concept of “technological mourning,” defined as the affective response to the perceived loss of a digital partner. The framework draws on theory of individuation, second-order cybernetics, and distributed cognition to interpret user reactions as signals of disturbances within human–AI systems. https://www.academia.edu/journals/academia-mental-health-and-well-being/articles?source=journal-top-nav

Type 1 Plasminogen Deficiency Overview by Madaline Spencer| Published on: Mar 13, 2026

Type 1 Plasminogen Deficiency Overview by Madaline Spencer| Published on: Mar 13, 2026 Amy Shapiro, MD, a pediatric hematologist and the Medical Director and CEO of the Indiana Hemophilia and Thrombosis Center in Indianapolis, provides CheckRare an overview on type 1 plasminogen deficiency (PLGD-1). https://checkrare.com/type-1-plasminogen-deficiency-overview/

8-Week Follow-Up Data of RAP-219 for the Treatment of Focal Onset Seizures by Madaline Spencer| Published on: May 11, 2026

8-Week Follow-Up Data of RAP-219 for the Treatment of Focal Onset Seizures by Madaline Spencer| Published on: May 11, 2026 William W. Motley, MD, RAP-219 Program Leader at Rapport Therapeutics, discusses follow-up data of RAP-219 for the treatment of focal onset seizures. https://checkrare.com/8-week-follow-up-data-of-rap-219-for-the-treatment-of-focal-onset-seizures/

MHRA Approves New Prophylactic for Rare Swelling Disorder Edited by Zeel Mehta Medscape UK May 11, 2026

https://www.medscape.com/viewarticle/mhra-approves-new-prophylactic-rare-swelling-disorder-2026a1000f05 The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved Dawnzera (donidalorsen, Otsuka Pharmaceutical Netherlands B.V.) for the prevention of swelling attacks in patients aged 12 years or older with hereditary angioedema. The approval was granted through the International Recognition Procedure.